Innate Immunity and Cancer Pathophysiology.

Area of Science:

• Oncology
• Immunology
• Cancer Biology

Background:

• Chronic inflammation is a known risk factor for various cancers, including gastric, colon, and hepatic cancers.
• Tumors induce an inflammatory response orchestrated by the innate immune system, influencing tumor growth and adaptive immunity.
• The role of inflammation in cancer is complex, potentially supporting or restraining tumor progression based on the tumor microenvironment's immune cell balance.

Purpose of the Study:

• To explore the dual role of inflammation in cancer development and progression.
• To highlight the heterogeneity and plasticity of innate immune cells within the tumor microenvironment.
• To discuss the potential for classifying tumors based on immune profiles and developing targeted immunotherapies.

Main Methods:

• Review of current research on inflammation, innate immunity, and cancer.
• Analysis of the plasticity and heterogeneity of innate immune cells in various tumor contexts.
• Discussion of emerging strategies for immune-based tumor classification and therapy.

Main Results:

• Innate immune cells are highly heterogeneous and plastic, with phenotypes varying by tumor type, stage, and treatment.
• The balance of immune cells and signals in the tumor microenvironment dictates whether inflammation promotes or inhibits tumor growth.
• Understanding innate immune cell roles offers opportunities for novel cancer diagnostics and therapeutics.

Conclusions:

• Harnessing knowledge of innate immunity can lead to improved tumor classification for prognosis and treatment selection.
• Targeting innate immune cells presents a promising avenue for developing novel therapeutic strategies to activate antitumor immune responses.
• Future research will focus on leveraging immune cell heterogeneity for personalized cancer medicine.